Clinical Trials Browser

Phase EARLY_PHASE1 × abemaciclib × 90 days × Clear all

NCT04391595 2026-03-06

LY3214996 Plus Abemaciclib in Recurrent Glioblastoma Patients

Phase EARLY_PHASE1 Completed

Glioblastoma, Glioma